Our new pick is: ACOL – Acology Inc.

*First things first, we wanted to address a mistake we made.  ACOL’s revenues were NOT up 151%, their gross profit had increased 151%.  Their sales revenue had increased 80% year over year*

We uncovered some new details regarding ACOL’s sales.  In 2013 ACOL sold approximately 125,000 units, during 2014, 123,000 units and through March 31st, 2015 they have already sold 58,000 units! This means ACOL is on track to nearly double its units sales numbers if it can keep up this pace!

ACOL closed at just .0024 today and has traded for a bit over 2.5c a share in the past months so needless to say, we feel there is upside potential at this price.

  • ACOL’s  gross profit increased 151% from 2013 to 2014!
  • ACOL has developed the very first patented air tight, water tight, and smell proof medical grade container with built in grinder.Uses FDA approved medical grade plastics and environmentally safe
  • ACOL recorded record sales in February 2015
  • ACOL has entered into discussions with some huge names such as Bayer International Healthcare and Henry Schein Medical Products to place their products within their outstanding companies
  • ACOL is trading for less than 1/10th of its recent high from last month

First things first, lets talk about the financials released in the annual report on April 15th.  ACOL saw a dramatic increase of 151% in gross profit while sales increased from 254,992 in 2013 to 460,756 in 2014.

                                    Fiscal 2013        Fiscal 2014     

Gross Profit                  $       125,703     $       315,716    


Sales                          $        254,992   $      460,756

We are loving the numbers, especially considering ACOL has a last of .0024 a share!

ACOL is an innovative company operating in the fields of manufacturing, branding, sales, consulting and has most recently brought a revolutionary design to the forefront, the first-ever polypropylene air-tight, water-tight , smell-proof delivery and storage system which also embodies a grinding component.ACOL’s Containers give consumers the ability to store, carry, and dispense items such as pharmaceuticals, herbal remedies, teas and many other solid and/or liquid contents with ease.Its lead product can be seen here: http://themedtainer.com/The Medtainer is versatile in its design, being able to traverse numerous consumer needs on the go. Through the product’s ability to embody both air-tite & grinding capabilities, we are able to transcend various markets and expand its everyday uses. Although originally engineered as a solution to break down medication for the needs of Pediatric and Geriatric patients, the medtainer has now been adopted as an application into markets/industries such as tea,culinary, coffee, medicinal marijuana,pharmaceuticals&veterinary medicine.

We are very proud and humbled to be able to simplify and assist countless consumers in their everyday lives from the fields mentioned with such an innovative product that is composed of FDA approved medical grade plastics and is environmentally safe.

We know for sure the Medtainer must be selling well because ACOL announced on March 5 that its sales for February, 2015 eclipses projections and have set records for the best month in the company’s history!

Not only is ACOL reporting record sales for last month but apparently they have entered into discussion with some seriously huge names!

Can you imagine what would happen if a company trading at sub penny levels announced a partnership with Bayer International Healthcare?

Take a look at this quote from ACOL’s PR below:

“Acology’s presence at the Western Veterinary Conference in Las Vegas at the end of February, where we introduced “The Pet-Tainer”, has developed new interest in the company’s signature product. Although preliminary, we have entered intomeaningful discussions with Bayer International Healthcare and Henry Schein Medical Products to place Acology products with their outstanding companies”

Just so you can further understand how huge both these companies are, Bayer AG had revenues of 42B dollars last year and Henry Schein did just over 10B in revenue last year.

More recently, on April 6th, 2015, ACOL announced that it has completed an agreement with the Jason Hornung Advertising Agency and launched a new, aggressive campaign emphasizing increased internet and E-commerce sales and social media penetration.

This new program will enable the company to market its products to all the industries it serves including veterinary, geriatrics, pharmaceutical and the medical cannabis market.

Based in Tucson, Az. The Hornung Agency specializes in retail web campaigns that are sharply focused on driving traffic, increasing social-media branding and presence and funneling customers to end-point sales. Acology’s new e-commerce campaign will have a direct impact on social media heavy-hitters, including the ‘Big4’; Facebook, Instagram, Twitter and Google. The Hornung Agency has developed successful campaigns for a diverse array of companies, such as MPACT Wealth, The Thrive Doctors, Game Academy and the Trey Lewellen Companies.

For a company with exploding sales and revenue growth it really is amazing to see it with a last of only .0024 a share.  We love where ACOL is headed and believe if they can keep up the progress, the market will have to respond positively eventually.

Please begin your research now!

This newsletter is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Owners of this newsletter may buy and sell shares at the open market at any time during this email program. Because of this conflict, individuals are strongly encouraged to not using this newsletter as the basis for any investment decision. We are not responsible for any losses you may incur while using this newsletter and its services. If you do not agree with this statement then please leave this service immediately. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.  We have been compensated two thousand dollars cash via wire transfer for this marketing awareness campaign on ACOL by a third party Initial Investments LLC.